E70.33
Albinism with hematologic abnormality
Clinical Classification Guidelines
Medical Intelligence & Overview
Albinism with hematologic abnormality, classified under ICD-10 code E70.33, is a rare genetic condition characterized by a lack or reduction of melanin pigmentation in the skin, hair, and eyes, along with blood-related abnormalities. This condition results from genetic mutations affecting both pigment production and blood cell function or count. While albinism primarily impacts appearance and vision, the associated hematologic abnormality can influence blood health and requires attention. Awareness of this condition involves understanding its causes, symptoms, diagnostic approaches, and potential management options, aiding in comprehensive care and support for affected individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the OCA (Oculocutaneous Albinism) genes associated with melanin production Additional mutations influencing blood cell development or function, leading to hematologic abnormalities Inheritance patterns typically autosomal recessive, meaning both parents must carry the gene mutation for a child to be affected Potential environmental factors are generally not implicated in the development of this condition
Key Symptoms: Significant reduction or absence of pigmentation in skin, hair, and eyes resulting in very light or white appearance Visual impairments such as nystagmus (involuntary eye movement), increased sensitivity to light (photophobia), and reduced visual acuity Blood-related symptoms, including anemia, increased susceptibility to bleeding, or abnormal blood cell counts Potential skin issues due to lack of pigmentation, such as increased risk of sunburn and skin damage In some cases, skin abnormalities and immune system challenges related to hematologic issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, family history assessment, and laboratory testing. Specific steps include: - Detailed physical examination focusing on skin and eye pigmentation - Ophthalmologic assessments to evaluate visual function - Blood tests to identify anemia or other blood cell abnormalities - Genetic testing to detect mutations in genes associated with albinism and hematologic conditions - Skin biopsies or pigmentation assessments if needed Early diagnosis is vital for managing vision problems and addressing blood-related issues effectively.
Treatment Protocols: Management of albinism with hematologic abnormality focuses on symptom control and preventive care. While there is no cure for the genetic causes, treatment options include: - Regular ophthalmologic evaluations and corrective lenses for visual impairments - Sun protection measures, such as broad-spectrum sunscreens, protective clothing, and sunglasses - Blood work monitoring to detect and address anemia or other blood disorders promptly - Medications or therapies to manage specific hematologic abnormalities, as prescribed by a healthcare professional - Genetic counseling for affected individuals and family planning - Supportive therapies including vision aids and skin care routines Comprehensive care often involves a multidisciplinary team, including dermatologists, hematologists, and eye specialists, to optimize quality of life.
Clinical Advice & FAQs
Billing Guidance
Is E70.33 a billable ICD-10 code?
Yes, E70.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E70.33?
Clinical documentation must specify the nature of Albinism with hematologic abnormality and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
